SCHEMBL8813006

SCHEMBL8813006

Nc1ccc(S(=O)(=O)c2cc[c]c(O)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.55
TSHR P16473 3/20 0.55
LMNA P02545 3/20 0.55
MPO P05164 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
PKM P14618 2/20 0.53
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
NPC1 O15118 1/20 0.44
CYP2C19 P33261 1/20 0.42
NT5E P21589 1/20 0.42
HKDC1 Q2TB90 1/20 0.42
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
AGO2 Q9UKV8 2/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11436654 0.82 HTR6 (0.52) HTR6TSHRLMNAALDH1A1GAA
SCHEMBL28422858 0.75 HTR6 (0.73) HTR6TSHRLMNAMPOCYP3A4
Dapsone SCHEMBL2031998 0.74 HTR6 (0.89) HTR6TSHRLMNAMPOCYP3A4
SCHEMBL324893 0.74 HTR6 (1.00) HTR6TSHRLMNAMPOCYP3A4
Dapsone SCHEMBL1219599 0.74 HTR6 (1.00) HTR6TSHRLMNAMPOCYP3A4
SCHEMBL10596934 0.74 HTR6 (1.00) HTR6TSHRLMNAMPOCYP3A4
Dapsone SCHEMBL21428 0.74 HTR6 (1.00) HTR6TSHRLMNAMPOCYP3A4
Dapsone SCHEMBL5055312 0.74 HTR6 (1.00) HTR6TSHRLMNAMPOCYP3A4
SCHEMBL6241506 0.74 ALDH1A1 (0.44) TSHRLMNACYP2C9ALDH1A1CYP2C19
SCHEMBL900296 0.73 HTR6 (0.76) HTR6TSHRLMNAMPOCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5658952-A REDUCTION IN LEVEL OF INFECTION; ANTIPROTOZOA AGENTS JACOBUS PHARMACEUTICAL CO., INC. (US) 1997-08-19 US disclosed
WO-1997007795-A2 1-[4-(4'-SULFANILYL)PHENYL]UREA AND DERIVATIVES FOR THE TREATMENT OF LEISHMANIASIS JACOBUS PHARMACEUTICAL COMPANY, INC. (US) 1997-03-06 WO disclosed